RFID Costs A Hurdle For OTC Industry; Wal-Mart Pushes For Implementation
This article was originally published in The Tan Sheet
Executive Summary
The high cost of Radio Frequency Identification technology may preclude its expanded use in the OTC drug arena even as firms are exploring the technology for use with Rx drugs, according to Tim Marsh, technical manager of global packaging technology for Pfizer